Dishman Carbogen Amcis Limited
All news and filings related to Dishman Carbogen Amcis Limited.
View all news & filings- Low impact
Dishman Carbogen Amcis Limited's 19th AGM Concludes with All Resolutions Passed
Dishman Carbogen Amcis Limited's 19th AGM was held on September 30, 2026. All five resolutions, including financial statement adoption and director re-appointments, were passed. Voting results were submitted to regulatory bodies.
Read the summary - Low impact
Dishman Carbogen Amcis Limited Concludes 19th AGM on Sept 30, 2026
Dishman Carbogen Amcis Limited held its 19th AGM on September 30, 2026, approving financial statements for FY26. Key resolutions included re-appointing Mr. Arpit J. Vyas as Director and M/s. T R Chadha & Co. LLP as Statutory Auditors for five years. Remuneration for Non-Executive Directors was also approved.
Read the summary - Low impact
Dishman Carbogen Amcis Limited's 19th AGM: All Resolutions Passed
Dishman Carbogen Amcis Limited's 19th AGM was held on September 30, 2026. Shareholders approved the Audited Standalone and Consolidated Financial Statements for FY26, re-appointed Mr. Arpit J. Vyas as Director, re-appointed Statutory Auditors, and approved Non-Executive Director remuneration. All resolutions passed.
Read the summary - Low impact
DCAL Allots ₹15 Crore Worth of Debentures via Private Placement
Dishman Carbogen Amcis Limited has allotted 1,500 Non-Convertible Debentures worth ₹15 crore. The allotment was approved by the Management Committee on September 28, 2026. These debentures have a face value of ₹1,00,000 each and a maturity date of March 28, 2028.
Read the summary - Low impact
Dishman Carbogen Amcis Limited: Trading Window Closed From Oct 1 For Q2 FY27 Results
Dishman Carbogen Amcis Limited will close its trading window from October 1, 2026. This closure is for directors, designated persons, and their immediate relatives. The window will reopen 48 hours after the announcement of the un-audited financial results for the quarter and half-year ending September 30, 2026.
Read the summary - Medium impact
Dishman Carbogen Amcis subsidiary CARBOGEN AMCIS AG's Switzerland site clears US FDA inspection.
Dishman Carbogen Amcis Limited's subsidiary, CARBOGEN AMCIS AG, successfully completed a US FDA inspection at its Vionnaz, Switzerland manufacturing site. The inspection concluded without any observations, reinforcing the company's commitment to quality standards.
Read the summary - Low impact
Dishman Carbogen Amcis Limited Announces 19th AGM on Sep 30, 2026
Dishman Carbogen Amcis Limited will hold its 19th Annual General Meeting on September 30, 2026, via video conference. Remote e-voting is available from September 27 to September 29, 2026. The cut-off date for voting is September 23, 2026.
Read the summary - Low impact
Dishman Carbogen Amcis Ltd. Announces 19th AGM on Sep 30, 2026, Submits Annual Report FY26
Dishman Carbogen Amcis Limited will hold its 19th AGM on September 30, 2026, via VC/OAVM. The company submitted its FY26 Annual Report, including financial performance with Revenue from Operations at ₹29,319 million and EBITDA at ₹5,656 million. Remote e-voting is available from September 27-29, 2026.
Read the summary - Low impact
Dishman Carbogen Amcis Limited announces 19th AGM on Sep 30, 2026, via VC/OAVM
Dishman Carbogen Amcis Limited will hold its 19th AGM on September 30, 2026, via VC/OAVM. Annual Report 2025-26 will be shared electronically. Shareholders should register email addresses for access.
Read the summary - Low impact
Dishman Carbogen Amcis Ltd. to hold 19th AGM on September 30, 2026
Dishman Carbogen Amcis Limited will hold its 19th Annual General Meeting on September 30, 2026. The meeting will be conducted via Video Conference and Other Audio Visual Means.
Read the summary - Low impact
Dishman Carbogen Amcis: Vice President (Operation) Mr. Deepak Mittal Resigns Effective Aug 27, 2026
Dishman Carbogen Amcis Limited announced the cessation of Mr. Deepak Ram Chandra Mittal, Vice President (Operation). His relieving from the company is effective from the close of business hours on August 27, 2026. The NRC noted this change via a circular resolution on August 29, 2026.
Read the summary - Medium impact
Dishman Carbogen Amcis Limited Q1 FY27 Earnings Conference Call Transcript Released
Dishman Carbogen Amcis Limited released its Q1 FY27 earnings call transcript. Revenue for Q1 FY27 was INR 6,776 million, a 4% decrease YoY. EBITDA stood at INR 600 million. The company is planning to raise funds via external commercial borrowing at a 4% interest rate to prepay high-cost debt. For FY27, single-digit revenue growth is projected.
Read the summary - Low impact
DCAL Q1 FY27 Earnings Call Recording Available
Dishman Carbogen Amcis Limited has released the audio recording of its Q1 FY27 earnings conference call held on August 17, 2026. The call discussed financial results for the quarter ended June 30, 2026. The recording is available on the company's website.
Read the summary - Low impact
Dishman Carbogen Amcis Ltd Allots ₹75 Crore Non-Convertible Debentures
Dishman Carbogen Amcis Limited has allotted 7,500 Senior, Secured, Rated, Listed, Transferable, Redeemable, Taxable Non-Convertible Debentures. The total issue size is ₹75 Crores. The debentures have a face value of ₹1,00,000 each and mature on February 17, 2028.
Read the summary - High impact
Dishman Carbogen Amcis Q1 FY27: Revenue Drops 4.3% to ₹677.6 Crore
Dishman Carbogen Amcis reported Q1 FY27 revenue of ₹677.6 crore, down 4.3% YoY due to CDMO revenue deferment. Marketable Molecules revenue grew 48%. EBITDA margin fell to 8.9% from 19.9%. The company posted a Q1 FY27 net loss of ₹578.8 crore.
Read the summary - High impact
Dishman Carbogen Amcis Q1 FY27 Consolidated Loss of ₹57.88 Cr
Dishman Carbogen Amcis reported a consolidated net loss of ₹57.88 crore for Q1 FY27, down from a profit of ₹23.41 crore in Q1 FY26. Standalone net loss was ₹23.91 crore versus a profit of ₹2.67 crore. Total consolidated income decreased to ₹677.64 crore. The company incurred ₹1.69 crore in exceptional charges related to an abandoned QIP.
Read the summary - Low impact
Dishman Carbogen Amcis Revises Conference Call Details for Q1FY27 Results
Dishman Carbogen Amcis Limited will announce its Q1FY27 results on August 14, 2026. A conference call to discuss these results is scheduled for August 17, 2026, at 17:00 hrs IST. The company has revised the registration link for the call.
Read the summary - Medium impact
DCAL Schedules Q1FY27 Earnings Conference Call for August 17, 2026
Dishman Carbogen Amcis Limited will announce its Q1FY27 results on August 14, 2026. A conference call to discuss financial performance is scheduled for August 17, 2026, at 17:00 IST. Management representatives will attend the call.
Read the summary - Medium impact
DCAL Board Approves Issuance of NCDs Worth ₹75 Crores
Dishman Carbogen Amcis Limited's Board approved issuing NCDs up to ₹75 crores via private placement. The debentures will have a 10.00% annual interest rate, payable quarterly, with maturity in 18 months. Allotment is planned for August 17, 2026, and maturity for February 17, 2028.
Read the summary - Low impact
Dishman Carbogen Amcis Ltd. Notifies Transfer of Unclaimed Shares to IEPF
Dishman Carbogen Amcis Ltd. will transfer unclaimed equity shares to the IEPF by October 15, 2026. This applies to shares with undeclared dividends since FY 2018-19. Affected shareholders can claim shares from IEPF.
Read the summary - Low impact
DCAL submits SEBI compliance certificate for Q1 FY27
Dishman Carbogen Amcis Limited submitted a certificate for the quarter ended June 30, 2026, under SEBI (Depositories and Participants) Regulations. The RTA confirmed processing of dematerialised securities and updates to the register of members.
Read the summary - Low impact
Dishman Carbogen Amcis Subsidiary Commissions Solar Power Plant in Switzerland
Dishman Carbogen Amcis' subsidiary, CARBOGEN AMCIS AG, commissioned a 1,200 kWp solar power plant at its Neuland site in Switzerland. The system uses 2,448 photovoltaic modules over 6,200 m² for on-site consumption to reduce CO₂ emissions. This is part of the company's sustainability strategy.
Read the summary - High impact
Dishman Carbogen Amcis Approves FY26 Audited Results, Ups ECB Limit to CHF 200 Million
Dishman Carbogen Amcis approved audited FY26 results, with consolidated revenue at ₹2,931.90 crore and net profit at ₹97.45 crore. The company revised its ECB limit to CHF 200 million from Aamanya AG to refinance debt. Borrowing limits were increased to ₹4,000 crore. Re-appointment of auditors was recommended.
Read the summary - Low impact
Dishman Carbogen Amcis Limited (DCAL) Announces EGM Voting Results
Dishman Carbogen Amcis Limited (DCAL) held its Extra-Ordinary General Meeting (EGM) on June 19, 2026, via video conference. The company has submitted the voting results for agenda items discussed during the EGM, as per SEBI regulations.
Read the summary - Medium impact
Dishman Carbogen Amcis Limited holds EGM on June 19, 2026, approves borrowing limits and ECB loan
Dishman Carbogen Amcis Limited's EGM on June 19, 2026, passed resolutions to increase borrowing limits and approve an ECB loan from promoter entity Aamanya AG. The borrowing limit increase was approved by 127 members, while the ECB loan received assent from 124 members.
Read the summary - Low impact
Dishman Carbogen Amcis Limited Holds EGM on June 19, 2026, Passes Resolutions
Dishman Carbogen Amcis Limited held an EGM on June 19, 2026, passing resolutions to increase borrowing limits and approve a loan from promoter group entity Aamanya AG. The meeting was conducted via video conference.
Read the summary - Low impact
Dishman Carbogen Amcis Ltd. announces EGM on June 19, 2026, with e-voting details
Dishman Carbogen Amcis Limited will hold its EGM on June 19, 2026, via VC/OAVM. Remote e-voting is available from June 16 to June 18, 2026. The cut-off date for voting rights is June 12, 2026. CDSL is facilitating e-voting and meeting participation.
Read the summary - Medium impact
Dishman Carbogen Amcis to hold EGM on June 19th to raise borrowing limit to ₹4,000 Cr.
Dishman Carbogen Amcis will hold an EGM on June 19, 2026, to seek approval for increasing its borrowing limit to ₹4,000 Crores from the current ₹1,700 Crores. Shareholders will also vote on availing an ECB of up to CHF 200 Million from promoter entity Aamanya AG for refinancing debt and working capital needs.
Read the summary - Low impact
Dishman Carbogen Amcis Announces EGM on June 19, 2026
Dishman Carbogen Amcis Limited will hold its Extra-Ordinary General Meeting (EGM) on June 19, 2026, at 15:00 hrs via Video Conferencing. Shareholders are advised to register their email addresses for electronic communication and remote voting. The notice will be available on the company and stock exchange websites.
Read the summary - Low impact
Dishman Carbogen Amcis Ltd. to Hold EGM on June 19, 2026 for Borrowing Limit Increase
Dishman Carbogen Amcis Limited will hold an Extra-Ordinary General Meeting (EGM) on June 19, 2026. The EGM will seek shareholder approval for increasing borrowing limits and for a loan from a promoter group entity as a material related party transaction.
Read the summary - High impact
Dishman Carbogen Amcis Limited Releases Q4 FY26 Earnings Call Transcript
Dishman Carbogen Amcis Limited reported Q4 FY26 revenue of ₹851 crore, up 19% YoY. Full-year FY26 revenue was ₹2,932 crore, up 8%. The company plans to repay high-cost Indian debt with external commercial borrowing to reduce interest costs. Key growth drivers include CDMO and Vitamin D analog sales.
Read the summary - Low impact
DCAL: Audio Recording of Earnings Conference Call Held on May 20, 2026, Now Available
Dishman Carbogen Amcis Limited has released the audio recording of its earnings conference call held on May 20, 2026. The call discussed the financial results for the quarter and year ended March 31, 2026. The recording is available on the company's investor relations website.
Read the summary - High impact
Dishman Carbogen Amcis: Q4FY26 & FY26 Results & Investor Presentation
Dishman Carbogen Amcis reported Q4FY26 Net Revenue of ₹8,514 million (up 18.9% YoY) and FY26 Net Revenue of ₹29,319 million (up 8.1% YoY). EBITDA margins improved to 19.3% in FY26 from 17.3% in FY25. Net debt reduced to CHF 146.80 million. The company is focusing on oncology, with 12 molecules in Phase III.
Read the summary - High impact
Dishman Carbogen Amcis Approves FY26 Results, Upsizes ECB to CHF 200M, Reappoints Auditors
Dishman Carbogen Amcis approved FY26 audited results on May 19, 2026. The company will raise CHF 200 million (approx. ₹2452 Cr) via ECB from promoter Aamanya AG to refinance debt. Board also recommended re-appointment of auditors M/s. T R Chadha & Co. LLP for a second 5-year term.
Read the summary - High impact
Dishman Carbogen Amcis Ltd. Approves FY26 Results, Raises ECB Limit to CHF 200 Million
Dishman Carbogen Amcis Limited approved its audited financial results for the quarter and year ended March 31, 2026. The board approved raising External Commercial Borrowings (ECB) up to CHF 200 million (approx. ₹2452 Crores) from Aamanya AG to refinance existing debt. Borrowing limits will be increased to ₹4000 Crores. M/s. T R Chadha & Co. LLP recommended for re-appointment as statutory auditors for five years.
Read the summary - Medium impact
Dishman Carbogen Amcis to Announce Q4FY26 & FY26 Results on May 19; Concall on May 20
Dishman Carbogen Amcis Limited will announce its Q4FY26 and FY26 results on May 19, 2026. A conference call to discuss these results is scheduled for May 20, 2026, at 15:00 hrs IST. Management, including Global CFO Harshil Dalal, will participate.
Read the summary - Medium impact
Dishman Carbogen Amcis Subsidiary Passes Unannounced NMPA GMP Inspection in Shanghai
CARBOGEN AMCIS Shanghai, a subsidiary of Dishman Carbogen Amcis Limited, successfully completed an unannounced NMPA GMP inspection on April 14, 2026. The inspection, conducted by China's National Medical Products Administration, found no observations, confirming robust GMP compliance at the Shanghai facility.
Read the summary - Low impact
Dishman Carbogen Amcis Appoints Sandeep Jaiswal as Vice President (International Marketing)
Dishman Carbogen Amcis Limited appointed Sandeep Jaiswal as Vice President (International Marketing) effective April 20, 2026. Jaiswal has 27 years of experience in business development and marketing within the pharmaceutical and chemical sectors.
Read the summary - Low impact
DCAL: Certificate under SEBI Reg 74(5) for Q4 FY26 Received
Dishman Carbogen Amcis Limited received a confirmation certificate for the quarter ended March 31, 2026. The certificate, from RTA MUFG Intime India Private Limited, confirms processing of dematerialised securities as per SEBI regulations.
Read the summary - Medium impact
DCAL Secures Waiver on Financial Covenants for NCDs Issued Under ISIN INE385W07059
Dishman Carbogen Amcis Limited received consent for amendments to financial covenants on its ₹50 crore NCDs (ISIN INE385W07059) for FY ended March 31, 2026. Waivers were granted for Total Net Debt to EBIDTA, Adjusted Debt Service Coverage Ratio, and Interest Coverage Ratio.
Read the summary - Low impact
Dishman Carbogen Amcis: Trading Window Closed April 1, 2026 for FY26 Results
Dishman Carbogen Amcis Limited will close its trading window from April 1, 2026. The window will reopen 48 hours after the announcement of audited financial results for the quarter and year ending March 31, 2026.
Read the summary - Medium impact
Dishman Carbogen Amcis Approves Issuance of NCDs Worth ₹150 Crore
Dishman Carbogen Amcis approved issuing NCDs worth ₹150 crore. ₹100 crore will be issued in one or more tranches with an 18-month maturity. ₹50 crore, including a green shoe option, will be issued with a 24-month maturity. Both series offer a 10% coupon rate, payable quarterly.
Read the summary - Medium impact
Dishman Carbogen Amcis Clarifies Credit Rating Downgrade by India Ratings
Dishman Carbogen Amcis Limited clarifies its credit rating downgrade by India Ratings to 'A' and 'A1' with a negative outlook. The company noted an improvement in net leverage to 3.18x as of September 30, 2025, from 3.92x on March 31, 2025. EBITDA margins are also improving, excluding new French and Indian sites.
Read the summary - Medium impact
Dishman Carbogen Amcis Subsidiary Receives GMP Compliance Certificate for Netherlands Site
Dishman Carbogen Amcis Limited's wholly-owned subsidiary, CARBOGEN AMCIS B.V. in the Netherlands, has received a Certificate of GMP Compliance from the Health and Youth Care Inspectorate (IGJ) for its Veenendaal site.
Read the summary - High impact
India Ratings Downgrades DCAL's Debt to 'IND A'/Negative; Assigns Rating to New NCDs
India Ratings downgraded Dishman Carbogen Amcis Limited's (DCAL) debt instruments to 'IND A'/Negative, citing consistently high leverage. Proposed NCDs are rated 'IND A'/Negative. The company plans to raise ₹10 billion via QIP or preferential shares to reduce debt. EBITDA margins remain below pre-EDQM levels, though expected to improve to 19-20% in FY26.
Read the summary - Medium impact
Dishman Carbogen Amcis Releases Q3 FY26 Earnings Call Transcript
Dishman Carbogen Amcis reported Q3 FY26 revenue of ₹720 crore, up 5.5% YoY. Nine-month revenue grew 4.3%, with EBITDA up 27.3%. The company aims for 20-25% margins in Marketable Molecules and targets ₹500 crore India revenue in 12-18 months. Significant ramp-up expected in ADC supplies and French subsidiary to reach breakeven.
Read the summary - Low impact
DCAL Q3 FY26 Earnings Conference Call Audio Recording Available
Dishman Carbogen Amcis Limited has released the audio recording of its investor conference call held on February 4, 2025. The call focused on the company's financial results and performance for the third quarter ended December 31, 2025. The recording is available on the company's website.
Read the summary - Medium impact
Dishman Carbogen Amcis Q3 FY26 Net Revenue Rs. 719.8 Crore, Up 5.5%
Dishman Carbogen Amcis reported Q3 FY26 net revenue of ₹719.8 crore, up 5.5% YoY. 9MFY26 net revenue reached ₹2,080.5 crore, up 4.3% YoY. Q3 FY26 EBITDA was ₹113.1 crore with a margin of 15.7%, down from 20.5% in Q3 FY25. 9MFY26 EBITDA was ₹402.7 crore, with margins improving to 19.4%.
Read the summary - Medium impact
Dishman Carbogen Amcis Q3FY26 Investor Presentation: Revenue Up 5.5% YoY
Dishman Carbogen Amcis reported Q3FY26 revenue of ₹7,198 million, a 5.5% YoY increase. CDMO revenue grew 6.7% to ₹6,297 million. 9MFY26 revenue rose 4.3% to ₹20,805 million. EBITDA margin for Q3FY26 was 15.7%, down from 20.5% YoY, while 9MFY26 margin improved to 19.4%.
Read the summary - Medium impact
DCAL Q3 FY26 Unaudited Results: Consolidated Net Loss of ₹12.97 Crore
Dishman Carbogen Amcis Limited reported a consolidated net loss of ₹12.97 crore for Q3 FY26, with total income at ₹719.80 crore. Standalone results showed a net loss of ₹23.13 crore. The company's debt-equity ratio was 0.43 consolidated and 0.17 standalone. Goodwill amortization was revised to 99 years.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio